Vivoryon Therapeutics N.V.

Company Description

---

We are focused on developing innovative small molecule-based medicines. Driven by our passion for ground-breaking science and innovation, we strive to change the lives of patients in need suffering from severe diseases. We build on our in-depth expertise in understanding post-translational modifications to develop medicines that modulate the activity and stability of proteins which are altered in disease settings

Year founded

---

1997

Served area

---

Europe

Headquarters

---

Weinbergweg 22, 06120 Halle (Germany) – Netherlands

Shares outstanding

---

24,105,278

IPO

---

Jan. 1, 2000

Stock exchange(s)

---

Euronext Amsterdam